Parion Sciences: Parion Sciences Announces Publication of Phase 2 CLEAN-PCD

Published Phase 2 Study findings demonstrate safety and efficacy of idrevloride in hypertonic saline for treatment of primary ciliary dyskinesiaAbstract to be presented at 2023 European Respiratory Society Congress ALERT session DURHAM, N.C., Sept. 08, 2023 (GLOBE NEWSWIRE) - Parion Sciences Inc. today announced publication in The Lancet Respiratory Medicine of positive results of the [...]